Your browser doesn't support javascript.
loading
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns.
van Haren, Simon D; Pedersen, Gabriel K; Kumar, Azad; Ruckwardt, Tracy J; Moin, Syed; Moore, Ian N; Minai, Mahnaz; Liu, Mark; Pak, Jensen; Borriello, Francesco; Doss-Gollin, Simon; Beijnen, Elisabeth M S; Ahmed, Saima; Helmel, Michaela; Andersen, Peter; Graham, Barney S; Steen, Hanno; Christensen, Dennis; Levy, Ofer.
Afiliação
  • van Haren SD; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA. simon.vanharen@childrens.harvard.edu.
  • Pedersen GK; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. simon.vanharen@childrens.harvard.edu.
  • Kumar A; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Ruckwardt TJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Moin S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Moore IN; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Minai M; Infectious Disease Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Liu M; Infectious Disease Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Pak J; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
  • Borriello F; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
  • Doss-Gollin S; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
  • Beijnen EMS; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Ahmed S; Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
  • Helmel M; Generate Biomedicines, Cambridge, MA, USA.
  • Andersen P; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
  • Graham BS; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
  • Steen H; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Christensen D; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Levy O; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
Nat Commun ; 13(1): 4234, 2022 08 02.
Article em En | MEDLINE | ID: mdl-35918315
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / Vacinas contra Vírus Sincicial Respiratório Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / Vacinas contra Vírus Sincicial Respiratório Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos